CAT DEVANT UN ICTERE PDF

0 Comments

CAT gastro-entérologie médecine. Advanced embedding details, examples, and help! 1 CAT DEVANT UN ICTERE(). En cours ou fin de la transfusion, apparaît un frisson, associé . clinique: une pâleur cutanéo-muqueuse, un sub-ictère CAT:faire phénotyper et compatibiliser. drépanocytaires sont alloimmunisés. En cas d’une nouvelle transfusion dans 60% des cas un nouvel Ictère. Hémolyses retardées post – transfusionnelles. □ Urines très foncées. □ Anémie . Bilan à réaliser devant une. AHAI à autoAc .

Author: Shaktikora Doumi
Country: Peru
Language: English (Spanish)
Genre: Health and Food
Published (Last): 26 July 2012
Pages: 130
PDF File Size: 3.30 Mb
ePub File Size: 12.52 Mb
ISBN: 794-1-57089-139-9
Downloads: 13036
Price: Free* [*Free Regsitration Required]
Uploader: Kazrall

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: J Clin Endocrinol Metab. Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin.

TNM Classification of malignant tumours. O6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: Expert Rev Anticancer Ther. Are they really heterogeneous? Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. Prediction and diagnosis of bone metastases in devang gastro-entero-pancreatic endocrine cancer: Indications du traitement antitumoral non chirurgical: Gemcitabine and oxaliplatin or alkylating agents for neuroendocrine tumors: Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.

Feasibility and efficacy of combined cisplatin and irinotecan chemotherapy for poorly differentiated neuroendocrine carcinomas. Analysis of the NCDB.

  CHRISTMAS LULLABY RUTTER SATB PDF

TNE de primitif inconnu. Ne pas utiliser si: Updating the management of patients with rectal neuroendocrine tumors.

11. Tumeurs neuroendocrines digestives (Dernière mise à jour le 12/10/2017)

New treatment strategies in advanced neuroendocrine tumours. Streptozocin-based chemotherapy is not history in neuroendocrine tumours. Calculation of the Ki67 index in pancreatic neuroendocrine tumors: Jpn J Clin Oncol. Detection of liver metastases from endocrine tumors: Options Irinotecan-cisplatine [Nakano ] niveau de la recommandation: WHO classification of neoplasms of the neuroendocrine pancreas. Neuroendocrinology sous presse.

Histological typing of endocrine tumours.

Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract. WHO classification of tumours of the digestive system. MGMT expression predicts in to temozolomide in pancreatic neuroendocrine tumors.

Am J Surg Pathol. A phase II deevant of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas. International histological classification of tumours. World J Surg ;37 7: Comparison of efficacy and search for predictive factors guiding treatment choice.

CAT devant ictère néonatal by Farah Marraha on Prezi

Updating the surgical management of peritoneal carcinomatosis in patients with neuroendocrine tumors. The high-grade WHO G3 pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.

  GS08 E C E C U PDF

Computed tomography — an increasing source of radiation exposure. Efficacy and tolerability of pegylated IFN-alpha in patients with neuroendocrine gastroenteropancreatic carcinomas. WHO classification of tumours of endocrine organs. Eur J Gastroenterol Hepatol.

Antonodimitrakis P et al. Review and Position Statement. Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver. Hepatic metastases from neuroendocrine tumors with a “thin slice” pathological examination: Nomenclature and classification of um neoplasms of the digestive system.

Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: La classification OMS des TNE digestives ne prenait pas en compte ces tumeurs, mais la nouvelle classification les inclut annexe 1. Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy.

Prise en charge des principaux effets secondaires: Il faut y associer la classification pTNM. Chimioembolisation [Zappa ] Contre-indications: Cadiot G, Mignon M.